Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

MA06.02 Prospective Immunogenomic Profiling of Non-Small Cell Lung Cancer: Genomic and Immune Profiling Updates From Project ICON

Journal of Thoracic Oncology

English

P1.16-09 Surgical Result of Pathologic Stage III a Non Small Cell Lung Cancer: Have We Improved?

Journal of Thoracic Oncology

English

P2.01-16 Dynamic ctDNA Monitoring Revealed Novel Resistance Mechanisms and Response Predictors of Osimertinib Treatment in East Asian NSCLC Patients

Journal of Thoracic Oncology

English

P3.01-111 Efficacy and Safety of Cytotoxic Drug Chemotherapy After First-Line EGFR-TKI in Elderly Patients With NSCLC Harboring Sensitive EGFR Mutations

Journal of Thoracic Oncology

English

P3.03-13 Downregulation of miRNA-506 Mediates EGFR-TKI Resistance Through Inducing Sonic Hedgehog Signaling in Non-Small-Cell Lung Cancer Cell Lines

Journal of Thoracic Oncology

English

P3.12-03 Targeting DLL3 With AMG 757, a BiTE® Antibody Construct, and AMG 119, a CAR-T, for the Treatment of SCLC

Journal of Thoracic Oncology

English

MS32.01 Genetic Mouse Models (GEMMS)

Journal of Thoracic Oncology

English

P037 QSOX1/2 Regulates Lipoprotein [A] Expression and Is a Prognostic Biomarker in Cancer

Journal of Thoracic Oncology

English

Application of a Highly Sensitive Detection System for Epidermal Growth Factor Receptor Mutations in Plasma DNA

Journal of Thoracic Oncology

English

P1.16-62 a Nomogram to Predict Disease-Free Survival After Curative Resection of Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

MA06.02 Prospective Immunogenomic Profiling of Non-Small Cell Lung Cancer: Genomic and Immune Profiling Updates From Project ICON

P1.16-09 Surgical Result of Pathologic Stage III a Non Small Cell Lung Cancer: Have We Improved?

P2.01-16 Dynamic ctDNA Monitoring Revealed Novel Resistance Mechanisms and Response Predictors of Osimertinib Treatment in East Asian NSCLC Patients

P3.01-111 Efficacy and Safety of Cytotoxic Drug Chemotherapy After First-Line EGFR-TKI in Elderly Patients With NSCLC Harboring Sensitive EGFR Mutations

P3.03-13 Downregulation of miRNA-506 Mediates EGFR-TKI Resistance Through Inducing Sonic Hedgehog Signaling in Non-Small-Cell Lung Cancer Cell Lines

P3.12-03 Targeting DLL3 With AMG 757, a BiTE® Antibody Construct, and AMG 119, a CAR-T, for the Treatment of SCLC

MS32.01 Genetic Mouse Models (GEMMS)

P037 QSOX1/2 Regulates Lipoprotein [A] Expression and Is a Prognostic Biomarker in Cancer

Application of a Highly Sensitive Detection System for Epidermal Growth Factor Receptor Mutations in Plasma DNA

P1.16-62 a Nomogram to Predict Disease-Free Survival After Curative Resection of Non-Small Cell Lung Cancer